Skip to content

Determination of glycemic index (GI) of bread

Determination of glycemic index (GI) of bread - Determination of glycemic index (GI) of bread.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026069
Enrollment
26
Registered
2017-02-10
Start date
2017-02-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Glucose solution as reference (50g/150ml) wash out period (at least 5 days) bread A wash out period (at least 5 days) bread B Glucose solution as reference (50g/150ml) wash out period (at leas

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged between 20 and 50 years old at consent. (2) Fasting plasma glucose 70-126mg/dl (3) Subjects whose body mass index (BMI) is under 30kg/m2 (4) Subjects who understand the study procedures and agree to participate in the study by giving informed consent prior to the study.

Exclusion criteria

Exclusion criteria: 1) Subjects who have history of malignant diseases. 2) Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, organ). 3) Subjects who have previous medical history of drug and/or food allergy. 4) Subjects who have infectious diseases. 5) Subjects who have continuous intake of medicine and/or health food for carbohydrate metabolism 6) Subjects who donated over 200 mL blood within the last one month, and/or over 400 mL blood within the last three month. 7) Subjects with impaired glucose tolerance. 8) Subjects who is menstruating in this clinical test. 9) Females who are pregnant or lactating, and who could become pregnant or lactating during test period. 10) Subjects who plan to participate in other clinical tests. 11) Subjects who are not eligible for this study for some medical reasons.

Design outcomes

Primary

MeasureTime frame
Glycemic index(GI)

Secondary

MeasureTime frame
Postprandial blood glucose level, Postprandial maximum blood glucose level, Incremental blood glucose area under the curve GI; Subjects with fasting plasma glucose <100 mg/dL, and =>100 mg/dL, respectively.

Countries

Japan

Contacts

Public ContactMakoto Ichinohe

CPCC Company Limited Plan Sales Department

m.i@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026